Clinical Trials

The following related clinical trials and research studies are currently seeking participants at Massachusetts General Hospital. Search for clinical trials and studies in another area of interest.

News

  • MGH ALS Symposium Video - 5/12/2015, Research

    Hear from the MGH Neurology Department researchers and clinic staff dedicated to finding treatments and cures for ALS.

  • Dousing for donations - 8/15/2014, Mass General

    The MGH ALS Multidisciplinary Clinic and the Northeast ALS Consortium participated in the Ice Bucket Challenge on Aug. 8.

  • Calling all Veterans - 1/30/2014, Clinical

    Military veterans who are diagnosed with ALS are eligible for service-connected benefits.

  • Testing new drugs for ALS - 1/1/2010, Research

    Merit Cudkowicz, MD, director of the Mass General Neurological Clinical Research Institute, talks about clinical trials for Amyotrophic Lateral Sclerosis, also known as ALS, or Lou Gehrig's disease.

  • Turning thoughts into action - 6/15/2009, Mass General

    Dr. Leigh Hochberg from the Department of Neurology at Massachusetts General Hospital is using neurotechnology to harness brain signals that accompany movement. The ultimate goal of the work is to "turn thought into action," with the hope of one day assisting people with ALS, spinal cord injury and stroke to regain control over their environment.

Test & Procedures

  • Botulinum Toxin (Botox) Service

    Botulinum toxin (botox) treatments are available through the EMG laboratory in the Neuromuscular Disorders Unit to treat spasticity resulting from stroke, head injury, spinal cord injury or multiple sclerosis and dystonias.

Video

  • Ceftriaxone in ALS Webinar

    The Clinical Trial of Ceftriaxone in ALS

    A webinar recording explaining the design and scientific rationale behind the Clinical Trial of Ceftriaxone in Amyotrophic Lateral Sclerosis (ALS), commonly known as Lou Gehrig's disease.

  • Ceftriaxone in ALS Video

    Ceftriaxone Trial Video

    A video explaining the design and scientific rationale behind the Clinical Trial of Ceftriaxone in Amyotrophic Lateral Sclerosis (ALS), commonly known as Lou Gehrig's disease.

  • Neurology bicentennial logo

    Neurology Bicentennial Celebration, 2011 Part II

    Neurology Bicentennial Celebration, October 13, 2011. Clinical and research presentations on ALS, Stroke, Alzheimer’s Disease, and Parkinson’s Disease

  • respiratory assistance video

    Respiratory Assistance Video

    A video for ALS patients discussing and demonstrating uses of bipap and cough assist machines.

  • Dr. Merit Cudkowicz, recipient of MDA LOU GEHRIG HUMANITARIAN AWARD

    Congratulations to Dr. Merit Cudkowicz for receiving the MDA LOU GEHRIG HUMANITARIAN AWARD

    Congratulations to Dr. Merit Cudkowicz, MGH Neurology Department Chairperson and Director, MGH ALS Clinic, for receiving the MDA LOU GEHRIG HUMANITARIAN AWARD. This award is given to a researcher, physician, or clinician who supports MDA/ALS research initiatives and clinical services and continues to fight the battle against ALS. View her acceptance speech where she discusses reasons for hope in the future of ALS treatments.

  • ALS Symposium

    MGH ALS Symposium Video

    Hear from the MGH Neurology Department Chairperson and founder and member of the MGH ALS Multidisciplinary Clinic, Dr. Merit Cudkowicz; Director of the MGH Multidisciplinary Care Clinic, Dr. James Berry; as well as the many researchers and clinic staff dedicated to finding treatments and cures for ALS.